Sensus Healthcare, Inc. (NASDAQ:SRTS) insider Stephen Brad Cohen sold 3,908 shares of Sensus Healthcare stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $6.00, for a total transaction of $23,448.00. Following the transaction, the insider now directly owns 983,583 shares of the company’s stock, valued at $5,901,498. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of Sensus Healthcare, Inc. (NASDAQ SRTS) traded down 0.24% on Thursday, reaching $5.85. 101 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $4.53 and a 200-day moving average price of $4.32. Sensus Healthcare, Inc. has a 12-month low of $3.38 and a 12-month high of $6.50. The company’s market cap is $78.90 million.

Sensus Healthcare (NASDAQ:SRTS) last issued its quarterly earnings data on Thursday, August 3rd. The company reported ($0.06) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.14) by $0.08. Sensus Healthcare had a negative return on equity of 16.40% and a negative net margin of 13.31%. The company had revenue of $4.97 million during the quarter, compared to analysts’ expectations of $4.50 million. Equities research analysts anticipate that Sensus Healthcare, Inc. will post ($0.33) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This piece of content was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The correct version of this piece of content can be accessed at

A hedge fund recently bought a new stake in Sensus Healthcare stock. B. Riley Financial Inc. acquired a new position in shares of Sensus Healthcare, Inc. (NASDAQ:SRTS) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 104,794 shares of the company’s stock, valued at approximately $421,000. B. Riley Financial Inc. owned approximately 0.77% of Sensus Healthcare at the end of the most recent quarter. 9.68% of the stock is currently owned by institutional investors and hedge funds.

Several research analysts have issued reports on SRTS shares. Maxim Group started coverage on shares of Sensus Healthcare in a report on Tuesday, June 6th. They issued a “buy” rating and a $6.50 target price for the company. Zacks Investment Research cut shares of Sensus Healthcare from a “hold” rating to a “sell” rating in a report on Thursday, May 11th.

About Sensus Healthcare

Sensus Healthcare, Inc, formerly Sensus Healthcare, LLC, is a manufacturer of superficial radiation therapy devices. The Company designs, manufactures and markets medical devices specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy.

Insider Buying and Selling by Quarter for Sensus Healthcare (NASDAQ:SRTS)

Receive News & Stock Ratings for Sensus Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensus Healthcare Inc. and related stocks with our FREE daily email newsletter.